Scandinavian Tobacco Faces Analyst Downgrades Following Annual Report

Major banks lower price targets as market caution overshadows stable dividend and margin goals. Stock nears oversold levels after 30% YTD decline.

Market analysts have significantly lowered their price targets for Scandinavian Tobacco Group A/S in the wake of its 2025 annual results. The company's presentation of stable dividends and specific margin goals for the current year has done little to dispel a prevailing sense of market caution. The effectiveness of its operational efficiency programs in countering persistent industry headwinds will be tested over the coming months.

Revised Price Targets Reflect Caution

Institutional investors moved swiftly to adjust their valuations after the company released its full-year figures on March 4th. The updated assessments from leading banks underscore a market shift towards a more guarded, watchful stance regarding the manufacturer's near-term prospects.

Key analyst revisions include:
* Deutsche Bank: Reduced its target price from 90 DKK to 77 DKK, maintaining a 'Hold' rating.
* DNB Carnegie: Lowered its target from 93 DKK to 80 DKK, also with a 'Hold' recommendation.

These adjustments signal that current macroeconomic challenges are being weighted more heavily than the firm's longer-term growth potential in the analysts' current evaluations.

Financial Metrics and Shareholder Returns Under Scrutiny

In a bid to underscore operational stability, Scandinavian Tobacco's management has provided an adjusted EBIT margin forecast of 13.0% to 14.5% for the 2026 financial year. This target range now stands as the primary benchmark for investors to gauge the group's cost efficiency.

Despite the challenging environment, the company is holding firm on its capital allocation strategy. A proposed dividend of 4.50 DKK per share aims to maintain shareholder loyalty. However, the power of this payout to stimulate fresh buying interest remains uncertain. The equity has come under substantial pressure, losing more than 30% of its value since the start of the year. From a technical perspective, with a Relative Strength Index (RSI) of 33.3, the stock is approaching oversold territory. This follows the recent establishment of a new 52-week low at €8.98 on March 9th.

The Road Ahead for 2026

Achieving the projected EBIT margin will be the central measure of operational resilience as the year progresses. Market participants will be closely monitoring how shifting consumer behavior and international trade conditions impact the tobacco producer's margin stability. Throughout this period, the consistent execution of its dividend plan is expected to remain a crucial pillar supporting the company's valuation.